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Available online 16 September 2016Background: Information is scarce about the geographic variation in time trends of mortality from coronary heart
disease (CHD).We aimed to describe trends in death rates, absolute number of deaths and years of life lost (YLL)
due to CHD among men and women in Portugal, by region, from 1981 to 2012.
Methods: The age-standardized mortality rates from CHD were estimated by sex and region. We used joinpoint
regression analysis to calculate the annual percent change (APC) inmortality and to identify points of signiﬁcant
change in the trend. The YLL due to prematuremortality for CHDwere computed using the Global Burden of Dis-
ease method.
Results: The age-adjusted mortality from CHD decreased between 1981 and 2012, both in men and women, but
with signiﬁcantly different APC by region. Smaller declines in rates were observed in Alentejo (men: APC 1993–
2012:−2.4%; women: APC 1991–2012:−2.4%). The greatest decline was observed in Madeira between 2003
and 2012, in men (APC:−7.6%) and women (APC:−9.7%). The decline in rates in Algarve started only after
2003, whereas it was consistent from 1981 in the North and started in the 1990s in most other regions. A de-
crease in the number of deaths was only observed after 2000. The YLL from CHD decreased from 1981 to 2012,
mainly after 2000.
Conclusions: In Portugal, between 1981 and 2012, relative declines of CHDmortality indicators were different by
geographic region. Consistent decreases in mortality rates were only observed in the Centre, Lisbon and North,
the most populated and urbanized regions.





Cardiovascular diseases (CVD) are themost common cause of death.
In 2012, almost half of non-communicable disease deaths worldwide
were caused by CVD (17.5 million deaths), more than double the num-
ber of deaths caused by cancers [1,2]. CVD are responsible for close to
half of all deaths in Europe (over 4 million deaths per year), with coro-
nary heart disease (CHD) accounting for 20% of all deaths in Europe an-
nually (nearly 1.8 million deaths) [2]. Themost up-to-date data on CVD
still show disparities in the death rates between European countries,
with Central and Eastern Europe having higher rates than Northern,logia Clínica, Medicina Preditiva
o Porto, Alameda Prof. Hernâni
).
eliability and freedom from bias
.Southern and Western Europe [2]. Within-country CVD mortality in-
equalities have been reported in several European countries, by region,
socioeconomic characteristics and country of birth [3–5].
CVD and CHD death rates have been consistently falling across most
but not all European countries; the timing and magnitude of this de-
crease also vary [2]. CHD mortality trends may also be different by de-
mographic groups, with young adults, especially women, experiencing
smaller decreases in CHD mortality rates in the two last decades [6].
Speciﬁc indicators such as years of life lost are needed to capture prema-
ture mortality due to CHD.
In Portugal, the age-adjusted mortality from CVD, in 2011, was
174.7/100,000 among men and 126.8/100,000 among women, and the
age-adjusted mortality rates from CHD are among the lowest in
Europe [2]. There was a decrease in the age-adjusted mortality from
CVD between 1980 and 2010 [7], and also from CHD [2], but there is
no information about the magnitude of these trends by region. Differ-
ences in health status by geographic region, namely in less populated
and less urban regions, are among the sizeable inequalities identiﬁed
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ducted by the World Health Organization [8]. This report states that it
is difﬁcult to assess and monitor the extent of the health inequalities
in Portugal, due to the lack of a monitoring system of health indicators
by target population groups, owing, at least in part, to a narrow inter-
pretation of the data conﬁdentiality law. A recent ecological study
showed geographic variation in hospital admissions and in-hospital
mortality of patients admitted with ischemic heart disease in Portugal
from 2000 to 2007, with the interior regions showing higher rates, not
fully explained by socio-demographic, economical and health resource
factors [9]. It is of interest to expand this observation to a longer period
and to consider total mortality, in addition to in-hospital mortality.
We aimed to describe time trends in death rates, absolute number of
deaths and YLL from CHD among men and women in Portugal, by re-
gion, during the period 1981–2012.
2. Methods
2.1. Sources of data
Estimates of population at risk aswell as the number of deaths fromCHD [Internation-
al Classiﬁcation of Diseases 9th revision clinical modiﬁcation, (ICD 9 CM) 410–414] were
obtained from ofﬁcial statistics [10,11].
All data were obtained from 1981 to 2012 for each sex in age groups (b1, 1–4, 5-year
age groups to 80–84 and ≥85 years), by region [Nomenclature of Territorial Units for Sta-
tistics (NUTS II): Alentejo, Algarve, Azores, Centre, Lisbon, Madeira and North].
2.2. Trends in mortality rates
We calculated age-standardized mortality rates per 100,000 by the direct method,
using the European standard population (2013 revision) as reference [12].
To calculate the annual variation in mortality and to identify points of signiﬁcant
change in the log-linear slope of the trend (joinpoints) [13] we performed a joinpoint re-
gression analysis, using Joinpoint® version 3.4 from the Surveillance Research Program of
the US National Cancer Institute. The analysis starts with the minimum number of
joinpoints, with no joinpoints corresponding to a straight line, testing if one or more
joinpoints signiﬁcantly improve model ﬁt. We set the minimum number of years before
the ﬁrst, after the last and between consecutive joinpoints as ﬁve. The best ﬁtting models
for the trends are presented formen and women by region. The estimated annual percent
change (APC) in mortality for each period was calculated taking the calendar year as the
independent variable and assuming a Poisson distribution.
2.3. Years of life lost
The years of life lost (YLL) due to premature mortality for CHD, by sex and age group,
in each geographic region, were computed using the Global Burden of Disease method
[14], by multiplying the number of deaths at each age by the life expectancy at the age
at which death occurs. We considered the recommended standard life expectancy at
birth of 80 years for men and 82.5 years for women. The average age at death was set to
the mid-point of each ﬁve-year age group, except for the oldest group in whom it was as-
sumed to be87.5 years [14].We applied a 3% time discount rate to assign lessweight to the
YLL corresponding to the periods more distant from the time of death than to those refer-
ring to the ﬁrst years after death, an age-weighting parameter to weight YLL in the very
young and the older ages less than other ages (Global Burden of Disease standard value
is 0.04) and an age weighting correction constant so that the introduction of age-
weights did not alter the total number of YLL (Global Burden of Disease standard value
is 0.1658) [14]. The total YLL for each gender and region was obtained by summing the
YLL of all age groups. Moving averages (over 3 years) for YLL were calculated.
3. Results
3.1. Trends in mortality rates
In Portugal, the age-adjusted mortality rates from CHD decreased
between 1981 and 2012, both in men and women, though with differ-
ent patterns by geographic region, both in magnitude and year of de-
cline onset.
In Portugal, amongmen, age-standardizedmortality rates decreased
from 195.6/100,000 in 1981 to 86.7/100,000 in 2012; and among
women, from 108.0/100, 000 to 50.0/100,000, in the same period.
Among men, Azores and Alentejo were the two regions with the
highest standardized mortality rates in 1981 (326.5/100,000 and
250.3/100,000), respectively and also in 2012 (174.9/100,000 and157.6/100,000, respectively). In the remaining regions, the standardized
mortality rates were similar among regions in 1981, ranging from
171.1/100,000 in Algarve to 186.4 in Lisbon, while in 2012 the North
showed a lower standardized mortality rate than all other regions
(66.4/100,000). Among women, Azores and Alentejo were also the
two regions with the highest standardized mortality rates both in
1981 (148.4/100,000 and 164.6/100,000, respectively) and in 2012
(97.4/100,000 for both regions). In the remaining regions, themortality
rates in 1981 ranged from 87.1/100,000 in the Algarve to 139.7/100,000
in Madeira, while the North ranked again as the region with the lowest
mortality rate in 2012 (32.6/100,000) (Fig. 1).
When analysing the decreases in standardized mortality rates over
the study period, in the whole country 1993 and 2003 mark inﬂexion
points for progressively steeper declines in rates among men, with
APC ranging from −0.7% in 1981–1993 to −5.1% in 2003–2012.
Among women, inﬂexion points were observed in 1992 and 2003,
with APC ranging from−0.2% in 1981–1992 to−5.5% in 2003–2012
(Table 1).
Among men, the decline in rates in Algarve and Madeira started
later, only after 2003, whereas it was consistent from 1981 in the
North and started in the nineties in the other regions. Among women,
Algarve also started to experience a decrease in rates only after 2004,
whereas the North and Centre had consistent decreases in rates from
1981, and from the nineties in the remaining regions, except for Madei-
ra where a ﬂuctuating pattern was observed (Table 1, Fig. 1).
Among men, smaller relative declines in CHD mortality rates were
observed in Alentejo and in the Centre region (APC 1993–2012:
−2.4% and −3.3%, respectively), while among women the region
with the smallest decline was Alentejo (APC 1991–2012: −2.4%)
(Table 1, Fig. 1). The greatest relative decline was observed in Madeira
for the period 2003 to 2012, both in men (APC:−7.6%) and in women
(APC:−9.7%) (Table 1, Fig. 1).
The declines in mortality rates had similar magnitude over time be-
tween men and women, when analysing the country as a whole. How-
ever, in most regions, greater declines were observed among women
compared to men, with larger sex differences in the Centre (APC:
−5.7% vs−3.3%; women vs men), followed by Madeira (APC:−9.7%
vs−7.6%) and the North (APC:−6.2% vs−4.3%) (Table 1).
3.2. Number of deaths and YLL
Although the decrease in the age-adjustedmortality rates from CHD
started in the nineties in themajority of the Portuguese regions, the de-
crease in the number of deaths was only observed after 2000 (Fig. 2).
All over the country, the YLL from CHD were signiﬁcantly higher in
men. The YLL from CHD decreased from 1981 to 2012, both among
men and women, ranging from a 23.9% decrease in Alentejo to a 64.5%
decrease in Madeira, among men, and from a 4.8% decrease in Alentejo
to a 57.8% decrease in Madeira, among women (Table 2). This decrease
was mainly observed after the year 2000, and Lisbon and the North
were the two geographic regions with lowest YLL, both in men and
women, during the majority of the period studied (YLL in 2012,
among men: 7.09/1000 population in Lisbon and 4.43/1000 population
in the North; and among women: 4.91/1000 population in Lisbon and
2.70/1000 population in the North) (Table 2, Fig. 2).
4. Discussion
CHDmortality rates decreased in Portugal over the last 30 years, but
with geographic disparities, meaning that cardiovascular health in-
equalities persisted in the country throughout this period. Azores and
Alentejo started with the highest rates in 1981, and despite the de-
crease, still showed higher rates in 2012, although the difference from
the other regions was attenuated. The North, on the other hand, had a
mortality rate that was dissimilar to other regions, which began to di-
verge early in the nineties but maintaining the lowest rates until 2012.
Fig. 1. Time trends in age standardized (European population) mortality rates for coronary heart disease, by sex and region, 1981–2012.
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the number of deaths was only observed after 2000. The CHDmortality
trends in Portugal are similar to those observed in other developed
countries of the world, namely in Western Europe [15]. This decline
has generally been described at the national level, which masks any
existing differences between socioeconomic groups or geographic
regions.
From 1981 to around 2000 the increase in the population size and
the older age structure [11] exceeded the contribution of decrease in
rates to a lower mortality burden, explaining an increase in the numberof deaths due to CHD until 2000. The higher YLL from CHD in men is in
accordance with the fact that the difference of CHD risk by sex is signif-
icantly larger in young people. Lisbon and the North are the two regions
with the youngest population, explaining the lowest YLL observed [16].
The inequalities in CHD mortality trends by Portuguese region are
dependent on two main domains, namely 1) the prevalence of cardio-
vascular risk factors and 2) health-care related factors, including the dis-
tribution and quality of health resources, access to the services and
patterns of use of health care [17]. These factors are related not only
with socioeconomic conditions, but also with lifestyle choices,
Table 1
Annual percent change (95% conﬁdence intervals, CI) in coronary heart disease mortality rates, by sex and region, 1981–2012.
Men Women
Perioda Mortality rateb APC, % (95% CI)c Perioda Mortality rateb APC, % (95% CI)c
Portugal
1981–1993 195.6 −0.7 (−1.2 to−0.1) 1981–1992 108.0 −0.2 (−1.0 to 0.6)
1993–2003 180.7 −2.6 (−3.4 to−1.8) 1992–2003 105.6 −2.1 (−2.9 to−1.4)
2003–2012 139.2 −5.1 (−5.9 to−4.3) 2003–2012 83.3 −5.5 (−6.4 to−4.6)
Alentejo
1981–1993 250.3 0.1 (−1.0 to 1.2) 1981–1987 164.6 −3.3 (−6.7 to 0.2)
1993–2012 252.4 −2.4 (−3.0 to−1.9) 1987–1991 134.4 4.9 (−4.5 to 15.3)
1991–2012 163.0 −2.4 (−2.9 to−2.0)
Algarve
1981–2003 171.1 −0.7 (−1.4 to 0.0) 1981–2004 87.1 −0.4 (−1.2 to 0.4)
2003–2012 148.0 −5.4 (−7.8 to−2.9) 2004–2012 79.8 −6.5 (−10 to−2.8)
Azores
1981–1998 326.5 1.2 (0.4 to 1.9) 1981–1998 148.3 1.8 (0.7 to 3.0)
1998–2012 397.1 −5.7 (−6.7 to−4.7) 1998–2012 202.0 −5.1 (−6.5 to−3.7)
Centre
1981–1993 186.3 −0.8 (−1.8 to 0.2) 1981–2003 101.8 −1.2 (−1.6 to−0.8)
1993–2012 168.9 −3.3 (−3.8 to−2.8) 2003–2012 78.0 −5.7 (−7.7 to−3.8)
Lisbon
1981–1990 186.4 0.7 (−0.7 to 2.2) 1981–1991 116.0 0.9 (−0.2 to 2.0)
1990–2004 198.8 −1.9 (−2.6 to−1.3) 1991–2004 126.7 −2.2 (−2.9 to−1.5)
2004–2012 151.3 −6.2 (−7.5 to−4.9) 2004–2012 94.9 −6.3 (−7.7 to−5.0)
Madeira
1981–2003 194.3 −0.4 (−1.4 to 0.6) 1981–1986 139.7 −8.2 (−15.2 to−0.7)
2003–2012 177.0 −7.6 (−11.6 to−3.4) 1986–2003 90.9 0.8 (−0.5 to 2.1)
2003–2012 104.6 −9.7 (−12.8 to−6.5)
North
1981–1993 185.5 −1.5 (−2.5 to−0.5) 1981–2003 100.7 −2.5 (−3.2 to−1.7)
1993–2012 153.8 −4.3 (−4.8 to−3.8) 2003–2012 58.1 −6.2 (−9.0 to−3.3)
a Periods with constant log-linear trend identiﬁed in the joinpoint analysis.
b Mortality rate (/100,000), estimated age-standardized mortality rate at the beginning of the respective period.
c APC, annual percent change; 95% CI, 95% conﬁdence interval.
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instance, in Portugal, those forces promote the Mediterranean diet and
at the same time smoking among women [17].
The contribution of the reduction in risk factors to the decline of Por-
tuguese CHDmortality from 1995 to 2008 was estimated to be 42% and
the increase in the uptake of treatments contributed approximately 50%
[17]. Previous studies have analysed trends in the prevalence or means
of cardiovascular risk factors in Portugal [18–20]. In the last decades
there was a decrease in blood pressure levels, observed in middle-
aged and older adults, while among young adults the levels remained
approximately constant [18]. Self-reported diabetes and overweight/
obesity, on the other hand, increased in both sexes; while smoking
prevalence increased only among women [17,19–21]. These estimates,
very important to understand the main determinants of the CHD mor-
tality decline in Portugal, certainly conceal different proportions across
geographic regions.
There is no systematic and comprehensive information available
about trends in risk factors by Portuguese regions, but cross-sectional
studies on some cardiovascular risk factors distribution by Portuguese
region convey relevant information. According to the AMALIA study
[22], which included 38,893 individuals, with regional, gender and
age-group distribution representative of the Portuguese population, be-
tween October 2006 and February 2007, Azores, one of the regionswith
the highest standardizedmortality rate over the last three decades, was
the region with the highest prevalence of self-reported hypertension
(35.6%), hypercholesterolemia (25.6%), diabetes (15.4%) and over-
weight/obesity (77.7%). Algarve, Madeira and the North were the re-
gions with the lowest prevalence of hypercholesterolemia (15.6, 15.8
and 15.9%, respectively); Algarve and the North had also the lowest
prevalence of hypertension (18.3 and 19.3%, respectively) and diabetes(9.1 and 6.5%, respectively). The North had the lowest prevalence of
overweight/obesity (41.3%). Algarve was the region with the highest
self-reported prevalence of smoking (20.3%), and Madeira and the Cen-
tre region the lowest (11.9 and 12.8%, respectively). According to the
VALSIM study [23], carried out between April 2006 and November
2007, there were signiﬁcant regional variations in the prevalence of
metabolic syndrome, adjusted for gender and age: residents in the Al-
garve or in Lisbon and Tagus Valley had lower prevalence [odds ratio
(OR) (95% conﬁdence interval): 0.78 (0.66–0.92) and 0.83 (0.77–
0.91), respectively], while residents in the North or Centre regions had
higher prevalence (OR (95% conﬁdence interval): 1.11 (1.01–1.21)
and 1.08 (1.002–1.16), respectively). After adjusting for gender and
age, thehigher prevalence in Alentejo residentswasno longer observed,
probably due to its elderly population. Considering a possible different
individual's global risk of developing CHD proﬁle by region and there-
fore a probable different need of risk-factor lowering treatment for
CHD primary prevention within Portugal, data on time trends of differ-
ent drugs utilization by region, namely statins and blood pressure low-
ering agents, would help to compare CHD risk level and risk-factor
lowering treatment, analysing the importance of evidence based treat-
ment in the reduction of CHDmortality by region. If regionswith a faster
reduction in CHDmortality showed a larger increase in risk-factor low-
ering treatment, a positive effect of these agents on CHDmortality and a
risk-based prescription would be supported; however if a “discordant”
relation (slower reduction in mortality accompanied by a larger in-
crease in prescription) was observed, which was already observed
with statins in other settings [24], other factors apart from the actual
risk of the patients would emerge as an explanation. Available data do
not allow the quantiﬁcation of time trends in cardiovascular risk factors
by region, which would help to better understand the determinants of
Fig. 2. Time trends in years of life lost and in number of deaths for coronary heart disease, by sex and region, 1981–2012.
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we expect that these differences are partly explained by anunequal pre-
vention and control of risk factors per region.
The National Health Service (NHS) provides universal coverage, ﬁ-
nanced mainly through taxation, which should ensure avoidance of in-
equalities, at least in access to care. Treatment of CHD in Portugal should
therefore be equitable and based on clinical need, and not dependent on
age, sex, race, region of residence and other socio-economic factors. In-
deed the majority of acute coronary events are treated in public hospi-
tals, but long-term care of patients is also carried out by other
providers, both public and private [25]. Besides theNHS, the Portuguese
health care system has two other coexisting and overlapping players:special public and private insurance schemes for certain professions
(health subsystems) and private voluntary health insurance. Public pro-
vision is particularly responsible for primary and hospital care. Special-
ist consultations and diagnostic services, among other treatments, are
commonly provided also in the private sector, less accessible to the gen-
eral population [26]. Despite the NHS' supposed universal coverage, the
geographic distribution of health resources is heterogeneous [25]. Al-
garve and Alentejo are the regions with the lowest number of hospital
beds (2.1 and 2.2 per 1000 inhabitants in 2010, respectively). Azores
and Alentejo are the regions with the lowest physician workforce, ap-
proximately 2 doctors per 1000 inhabitants, about half the number at
the national level [27]. Additionally there are several access indicators,
Table 2
Years of life lost from 1981 to 2012, by region and sex.
Men Women
YLLa YLLa reduction (%) YLLa YLLa reduction (%)
1981 2012 1981–2012 1981 2012 1981–2012
Portugal 11.05 6.60 40.3 6.9 4.4 36.2
Alentejo 18.99 14.46 23.9 12.06 11.48 4.8
Algarve 13.10 9.05 30.9 6.74 4.44 34.1
Azores 20.60 10.11 50.9 11.07 6.53 41.0
Centre 12.75 7.15 43.9 7.75 4.87 37.2
Lisbon 10.09 7.09 29.7 6.65 4.91 26.2
Madeira 11.58 4.11 64.5 7.25 3.06 57.8
North 8.82 4.43 49.8 5.52 2.70 51.1
a YLL, years of life lost in years. The YLL of each year was calculated as the moving av-
erage over 3 years.
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of these indicators have improved in the last years at the national level,
namely the number of patients submitted to primary percutaneous cor-
onary intervention (primary PCI), that increased by 37.0% from 2009 to
2013, the mean delay time to coronary angiography, that decreased
from 22.3 days in 2009 to 13.7 days in 2013, or the number of patients
admitted through the coronary fast-track system that increased by
80.5% from 2009 to 2013. However, at the region level, these improve-
ments were not of the same magnitude. Considering speciﬁc cardiac
procedures, in 2013, Alentejo was the region with the lowest number
of patients submitted to primary PCI (170.9 per million of inhabitants)
and with the highest mean delay time after a coronary angiography is
indicated (30 days). Lisbon and the Algarve were the regions with the
highest number of patients submitted to primary PCI (506.4 and 429.5
per million of inhabitants, respectively); and Algarve and the North
were the regions with the lowest mean delay time after a coronary an-
giography is indicated (2 and 8.2 days, respectively). Additionally the
coronary fast-track system was not implemented at the same time in
the different Portuguese regions, with Alentejo being the region with
the latest implementation [25]. Despite the increase in theuse of recom-
mendedpharmacological therapy for secondary prevention after anACS
during hospitalization and at hospital discharge over the last two de-
cades in Portugal [28], there is no information on trends of utilization
of these drugs in this group of patients by region. Treatment with
invasive proceduresmay be dependent on access determinants, namely
access to catheterization laboratories, but the prescription of pharmaco-
logical treatment during hospitalization and at discharge only depends
on the medical decision. It would be important to evaluate variation in
trends of utilization of pharmacological therapy for secondary preven-
tion of ACS by region, and to understand their role in the different pat-
terns of decrease in mortality observed. All these data suggest that the
factors that determine the observed trends, even in regions with similar
CHD mortality trends, play through different causality pathways. Un-
derstanding the speciﬁc pathways operating in each region has the po-
tential to further reduce the burden of CHD.
Considering the ﬁve main patterns of CHD mortality trends at
country level recently proposed, Portugal was included in a pattern
characterized by the lowest age-standardized mortality rate and with
a consistent decrease throughout the period of analysis [29]. The Centre,
Lisbon and the North regions, where most of the population lives, a
young and more educated population that lives predominantly in
urban areas [16], were closest to this same pattern, while the remaining
regionsweremore similar to a pattern characterized by higher rates ob-
served until later, after 2000. This difference shows inequalities in car-
diovascular health by region.
When analysing the CHD mortality trends by sex, we found greater
declines among women. The most consistent sex differences in adult
global mortality are attributed to CHD, which is the most common vas-
cular condition with consistently greater age-adjusted mortality rates
and risks in men than women, across different countries [2]. LowerCHDmortality rates amongwomen are explained by a better risk factor
proﬁle, even though there is evidence of higher in-hospital mortality
after a cardiovascular event and lower access to evidence-based second-
ary prevention [30]. The smaller sex difference in CVD mortality after
midlife has traditionally been related to postmenopausal oestrogen de-
ﬁciency in women [31], but it might also be explained by the decelera-
tion of the age-related increase in male speciﬁc mortality in midlife,
whereas women's mortality rates steadily increase with age, with no
signiﬁcant or particular change at menopause [32]. The fact that greater
declines were observed among women might be the result of effective
primary and/or secondary prevention measures implemented among
this group. Despite the slight increase in the prevalence of smoking
among women, changes in the major cardiovascular risk factors in
Portugal contributed signiﬁcantly more to the CHD decrease among
women than among men (58% vs 29%), with greater differences by
sex observed in the decrease in the mean population systolic blood
pressure (6.5 mmHg inmen and 12.4mmHg inwomen), that were es-
timated to have prevented or postponed 40% of deaths in men and 72%
in women [17]. Interestingly, the effect of antihypertensive treatment
was small, similar in men and women, and therefore this difference
was mainly attributable to lifestyle changes [17]. The greater declines
in CHD mortality among women are also in accordance with a recent
study showing improvements in sex-differences in dischargemedications
of patients admitted with acute coronary syndromes in Portugal, after
adjusting for the potential confounding effect of age, co-morbidities, and
contraindications [33].
5. Limitations
The key factor to correctly interpret these results is good-quality
data on mortality, dependent on the coverage, accuracy of diagnosing
causes of death and correct coding. Portuguese mortality data have
high coverage and the underlying cause of death is certiﬁedby amedical
practitioner. Nevertheless there is still a high proportion of deaths (17%)
coded as ill-deﬁned causes [34] and validation studies are needed to
better measure the accuracy of causes of death diagnosis.
Although we used ICD-9, which has considerably less detail than
ICD-10,we aremeasuring CHD as a large group,without needing specif-
ic codes, which minimizes errors, even considering changes in coding
rules and revisions done during the period of the study.
6. Conclusion
Despite the large decrease in age-adjusted mortality and in the YLL
from CHD observed in Portugal, between 1981 and 2012, relative
declines and the respective periods were different by geographic region.
Recognition of these inequalities clearly underlies the need to implement
an objective and systematic approach to monitor cardiovascular risk fac-
tor prevalence and proportion of control, and uptake of evidence-based
treatments, both during acute events and in more stable phases, by re-
gion. Good quality data on determinants of CHD incidence and mortality
by region are essential to deﬁne speciﬁc targets for intervention.
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